Please join our expert faculty for a discussion on the pathophysiology and management of severe hypertriglyceridemia (sHTG). The faculty will review primary and secondary causes that increase triglyceride production and/or decrease catabolism, with a special focus on the relationship between sHTG, acute pancreatitis, and atherosclerotic cardiovascular disease. The role of apolipoproteins such as apoC-III will also be explored. A clinical perspective will also be given on the importance of rapidly lowering plasma triglycerides. A discussion on lifestyle factors, guidelines for management, and currently available treatments, highlights a clear unmet need for patients with sHTG. At the conclusion of the presentation, the expert faculty will be available for Q&A.